drugset / Trial / NCT07368569

A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the Body

NCT07368569 ↗

Phase 1 Completed 14 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 764198 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).

Timeline

Start
2026-02-06
Primary completion
2026-03-14
Completion
2026-03-17

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 764198 Unknown — Oral
Subject Metformin Small molecule — Oral

Indications

No indication recorded.